指南与共识湿疹皮炎与荨麻疹

撒哈拉以南非洲特应性皮炎立场声明:现状与路线图

Position Statement on Atopic Dermatitis in Sub-Saharan Africa: current status and roadmap.
指南 / 共识 · J Eur Acad Dermatol Venereol · 2019-01-01

2019年4月,首届ISAD全球会议在日内瓦召开,30名参会者来自17个撒哈拉以南非洲国家及WHO等机构。会议认定AD是SSA地区最常见的慢性炎症性皮肤病之一,需WHO与各国卫生部重点关注,并制定了以基本药物可及性、基层培训、传统 healers 参与等为重点的路线图。

要点

  • AD是撒哈拉以南非洲最常见的慢性炎症性皮肤病之一。
  • 路线图优先事项包括AD基本药物与润肤剂可及性。
  • 需加强基层卫生工作者培训以改善色素皮肤病的分诊。

核心结论

  • AD在撒哈拉以南非洲高度流行,需WHO与国家卫生部给予更密切的关注。
  • 已制定路线图,优先解决AD基本药物与润肤剂可及性、基层培训及传统 healers 参与等问题。

研究设计与样本

  • 为首届ISAD全球会议立场声明,2019年4月在日内瓦召开,30名参会者来自17个SSA国家及WHO、IFD等机构。

主要发现

  • AD是SSA地区最常见的慢性炎症性皮肤病之一。
  • SSA地区有效医疗面临障碍,包括至卫生机构路途遥远、资源有限及皮肤科专业人才缺乏。

关键数值与推荐

  • 路线图优先事项包括AD基本药物与器械(尤其润肤剂)可及性。
  • 需改善基层卫生工作者教育以实现 adequate triage,并开发针对非洲色素皮肤的教育材料。
  • 涉及传统 healers 的参与及一定程度的患者教育。

临床怎么用

  • 在SSA地区应优先保障AD基本药物与润肤剂的可及性。
  • 加强基层卫生工作者对色素皮肤病的识别与分诊培训。
  • 考虑将传统 healers 纳入AD管理路径并开展患者教育。

局限性

  • 原文未报告具体研究数据或系统评价结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The first International Society of Atopic Dermatitis (ISAD) global meeting dedicated to atopic dermatitis (AD) in Sub-Saharan Africa (SSA) was held in Geneva, Switzerland in April 2019. A total of 30 participants were present at the meeting, including those from 17 SSA countries, representatives of the World Health Organization (WHO), the International Foundation for Dermatology (IFD) (a committee of the International League of Dermatological Societies, ILDS www.ilds.org), the Fondation pour la Dermatite Atopique, as well as specialists in telemedicine, artificial intelligence and therapeutic patient education (TPE). RESULTS: AD is one of the most prevalent chronic inflammatory skin diseases in SSA. Besides neglected tropical diseases (NTDs) with a dermatological presentation, AD requires closer attention from the WHO and national Departments of Health. CONCLUSIONS: A roadmap has been defined with top priorities such as access to essential medicines and devices for AD care, in particular emollients, better education of primary healthcare workers for adequate triage (e.g. better educational materials for skin diseases in pigmented skin generally and AD in particular, especially targeted to Africa), involvement of traditional healers and to a certain extent also patient education, bearing in mind the barriers to effective healthcare faced in SSA countries such as travel distances to health facilities, limited resources and the lack of dermatological expertise. In addition, several initiatives concerning AD research in SSA were discussed and should be implemented in close collaboration with the WHO and assessed at follow-up meetings, in particular, at the next ISAD meeting in Seoul, South Korea and African Society of Dermatology and Venereology (ASDV) meeting in Nairobi, Kenya, both in 2020.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Schmid-Grendelmeier P, Takaoka R, Ahogo KC, et al. Position Statement on Atopic Dermatitis in Sub-Saharan Africa: current status and roadmap. J Eur Acad Dermatol Venereol. 2019. PMID: 31713914. doi:10.1111/jdv.15972

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。